Montreal, QC, and Dublin, Ireland – Clinical research organizations JSS Medical Research and Venn Life Sciences Holdings say they are working together in clinical research to provide “best in class” services to the pharmaceutical industry in North America and Europe. As part of the arrangement, JSS has acquired some assets of the Canadian subsidiary of Venn, operating under the corporate name Venn Life Sciences Ltd. As a result of the joint venture, Venn Life Sciences will cease operating independently in Canada and its president Dr Sanjay Machado will work as a resource for JSS and Venn to promote the joint venture arrangement between the two companies. Dr Machado will be based at JSS offices in Montreal.
“The joint venture arrangement was timely as part of the global growth strategy executed by JSS through targeted acquisitions and key strategic alliances,” says Dr John S Sampalis, CEO & CSO and founder of JSS. “The welcome addition of Venn’s strategic positioning in the European market and strengths in the area of monitoring and project management services will augmented the science-based services offered by JSS.”